DeuterOncology
DeuterOncology is a preclinical-stage biotech company developing cancer treatments founded in 2020.
1
Funding Rounds
$6.1m
Money raised
Overview
DeuterOncology is a preclinical-stage biotech company developing cancer treatments founded in 2020.
- Website:
- Headquarters: Brussels
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company DeuterOncology has raised a total of $6.1m in funding over 1 rounds.
Key Insights:
- DeuterOncology January 2023 Series A Funding Round: $6.1m
DeuterOncology January 2023 Series A Funding Round
$6.1m